XML 37 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Note 14 - Intangible Assets, Net
12 Months Ended
Dec. 31, 2022
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]

14.         Intangible assets, net

 

The following table summarizes our intangible assets comprising of Customer Relationships & Contracts (“CR&C”), Trademarks, Technology and Software as of  December 31, 2022 and 2021 (in thousands):

 

  

December 31, 2022

  

December 31, 2021

  

December 31, 2022

 
      

Accumulated

          

Accumulated

      

Weighted

 
  

Gross

  

impairment

      

Gross

  

impairment

      

average

 
  

carrying

  

and

  

Net book

  

carrying

  

and

  

Net book

  

remaining

 
  

amount

  

amortization

  

value

  

amount

  

amortization

  

value

  

life (years)

 

CR&C

 $222,200  $(118,221) $103,979  $222,200  $(98,271) $123,929   5.3 

Trademarks

  57,100   (32,921)  24,179   57,100   (29,392)  27,708   7.5 

Technology

  170,652   (71,191)  99,461   159,458   (60,979)  98,479   11.7 

Software

  11,556   (9,671)  1,885   8,754   (5,817)  2,937   0.8 

Total

 $461,508  $(232,004) $229,504  $447,512  $(194,459) $253,053   8.3 

 

Amortization expense for intangible assets was $37.4 million, $28.1 million and $28.2 million for the years ended December 31, 2022, 2021 and 2020, respectively.

 

During the first quarter of 2022, we acquired technology to bolster our well intervention and integrity product offering, resulting in an increase in intangible assets of $11.2 million which will be amortized over a five-year life. The impact of this asset acquisition is included in “Acquisition of technology” on the consolidated statements of cash flows. 

 

The following table summarizes the intangible assets which were acquired pursuant to the Merger (in thousands):

 

  

Acquired Fair Value

  

Weighted average life

 

CR&C

 $7,000   10.0 

Trademarks

  17,000   10.0 

Technology

  79,920   15.0 

Software

  871   1.0 

Total

 $104,791   13.7 

 

No impairment expense associated with our intangible assets was recognized during the years ended December 31, 2022 and 2021. We recognized impairment expense associated with our intangible assets of $60.4 million for the year ended December 31, 2020, which is included in “Impairment expense” in our consolidated statement of operations. Refer to Note 4 “Fair value measurements” for further details.

 

The following table summarizes our intangible asset impairment expense by operating segment for the year ended December 31, 2020 (in thousands):

 

2020:

 

CR&C

 

Technology

 

Trademarks

 

Total

NLA

 $10,262 $20,616 $11,437 $42,315

ESSA

 - 6,909 4,070 10,979

APAC

 - 7,100 - 7,100

Total

 $10,262 $34,625 $15,507 $60,394

 

Expected future intangible asset amortization as of December 31, 2022 is as follows (in thousands):

 

Years ending December 31,

    

2023

 $35,467

2024

 33,582

2025

 33,582

2026

 33,582

2027

 33,582

Thereafter

 59,709

Total

 $229,504